What does this video actually claim?
@gloriannytorresor's TikTok shows her GLP-1 weight loss results with 866.6K views, promising to share "more detailed results" on Instagram. The video appears to document her personal transformation using GLP-1 medications, though she doesn't specify which drug or dosage she's using.
The Spanish caption translates to "On Instagram I'm showing you the most followed results." Without seeing the full Instagram content she references, we're working with limited information about her specific claims.
This type of before-and-after content is everywhere on social media, but personal testimonials don't tell us much about what typical users should expect.
Do personal GLP-1 results match clinical data?
The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% average weight loss with 2.4mg semaglutide over 68 weeks. For tirzepatide, the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed 20.9% weight loss at the highest 15mg dose.
Individual results vary wildly. Some people lose 30% of their body weight, others see minimal changes. The trials show huge ranges within their averages.
What you see in someone's transformation video might be their peak result after months of treatment, not what they maintained long-term. The clinical trials measured sustained weight loss, which is harder to achieve.
What's missing from social media success stories?
These videos rarely mention side effects that affect 70-80% of users. Nausea, vomiting, and diarrhea are standard during the first few months. About 5-10% of people stop treatment because they can't tolerate the effects.
Timeline matters too. The STEP trials measured results at 68 weeks, not 8 weeks. Most dramatic transformations you see online took 12-18 months of consistent treatment.
Cost and access are huge factors. Semaglutide runs $1,000+ monthly without insurance coverage. Many people can't maintain treatment long-term, and weight regain is common after stopping.
Are there red flags in this type of content?
The biggest issue is when creators don't disclose which specific medication they're using or their dosage. Semaglutide, tirzepatide, and liraglutide have different efficacy profiles and side effect patterns.
Directing followers to Instagram for "more results" raises questions about whether this is educational content or marketing. Some influencers profit from telehealth referral codes or supplement sales.
Without medical context about the creator's starting health status, other medications, or lifestyle changes, these results can't predict what others might experience.
What should you actually know about GLP-1s?
GLP-1 medications work by slowing gastric emptying and reducing appetite through the incretin system. They're prescription drugs that require medical supervision, not lifestyle products you try based on TikTok videos.
The real data is impressive but comes with caveats. Weight loss typically plateaus around 12-16 months, and maintaining results requires ongoing treatment in most cases.
If you're considering these medications, focus on clinical trial data and FDA prescribing information, not social media testimonials. Individual success stories don't represent typical outcomes.